Announced
Completed
Financials
Tags
Single Bidder
Majority
Public
Tender Offer
Acquisition
Cross Border
Friendly
Switzerland
pharmaceutical products
biopharmaceutical company
Pharmaceuticals
Completed
Synopsis
CSL, a biotechnology company, completed the acquisition of Vifor Pharma, a pharmaceuticals company, for $11.7bn. “Vifor Pharma's strategy has been to focus towards continuing being a market leader in iron deficiency, nephrology and cardio-renal therapies. The offer provides an excellent strategic opportunity for Vifor Pharma to optimize future market opportunities from a position of strength and to create substantial value for all stakeholders," Jacques Theurillat, Vifor Pharma Chairman. On January 18, 2022, CSL published offer prospectus on public tender offer for all publicly held shares of Vifor Pharma.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.